Kidney Cancer

>

Latest News

Learning AE Management With Immunotherapy vs TKIs in RCC
Learning AE Management With Immunotherapy vs TKIs in RCC

May 22nd 2024

Hans Hammers, MD, and his team discuss the most pertinent treatment options for patients with renal cell carcinoma.

Scratching the Surface in Managing Advanced RCC
Scratching the Surface in Managing Advanced RCC

May 19th 2024

Exciting New Treatment Updates Are on the Horizon for Advanced RCC
Exciting New Treatment Updates Are on the Horizon for Advanced RCC

May 18th 2024

Pembrolizumab also demonstrated a disease-free survival benefit vs placebo for patients with clear-cell renal cell carcinoma.
Pembrolizumab Prolongs Survival in Clear-Cell RCC

April 18th 2024

Toripalimab plus axitinib is now an approved regimen in China for patients with medium- to high-risk unresectable or metastatic renal cell carcinoma.
Toripalimab Combo Receives Chinese Approval for Advanced RCC

April 10th 2024